Hepatic steatosis in HCV-infected persons in the direct-acting antiviral era

Hepatitis C virus (HCV) infects 130–170 million people worldwide. Recently, direct-acting antivirals have been shown to eradicate HCV infection in 90–95 % of non-cirrhotic patients depending on genotype, treatment experience, and regimen used. Similar rates are achieved among compensated cirrhotics,...

Descripción completa

Detalles Bibliográficos
Autores principales: Stevenson, Heather L., Utay, Netanya S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5530934/
https://www.ncbi.nlm.nih.gov/pubmed/28883965
http://dx.doi.org/10.1186/s40794-016-0038-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5530934/
https://www.ncbi.nlm.nih.gov/pubmed/28883965
http://dx.doi.org/10.1186/s40794-016-0038-5

Ejemplares similares